Ashley Dreier Biography and Net Worth

VP of HealthEquity

Ashley Dreier serves as Independent Director of the Company. She has been the Executive Vice President and Chief Information and Technology officer of HealthEquity since 2013 where she is responsible for leading technology and ensuring strategic alignment and execution of the platform strategy across the organization. Prior to joining HealthEquity, Ms. Dreier served as Vice President Technology and Product Development at Krames StayWell from 2008 to 2013, where she was responsible for strategy and delivery of the core product offering of consumer health information and wellness platforms. Prior to joining Krames StayWell she was Director of Product Development at GE where she led the delivery of corporate payment products. Her professional background also includes Director of Software Project Management and Director of Information Systems at Wolters Kluwer and Sr. Financial Analyst at Boeing Company. Ms. Dreier holds a B.S. in accounting and an M.S. in information systems both from the University of Utah. Ms. Dreier has been a member of our board of directors since May 2018.

What is Ashley Dreier's net worth?: The estimated net worth of Ashley Dreier is at least $5.57 million as of September 2nd, 2020. Ms. Dreier owns 58,694 shares of HealthEquity stock worth more than $5,572,995 as of December 21st. This net worth approximation does not reflect any other investments that Ms. Dreier may own. Learn More about Ashley Dreier's net worth.
How do I contact Ashley Dreier?: The corporate mailing address for Ms. Dreier and other HealthEquity executives is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. HealthEquity can also be reached via phone at (801) 727-1000 and via email at [email protected]. Learn More on Ashley Dreier's contact information.
Has Ashley Dreier been buying or selling shares of HealthEquity?: Ashley Dreier has not been actively trading shares of HealthEquity during the last ninety days. Most recently, Ashley Dreier sold 16,250 shares of the business's stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $60.00, for a transaction totalling $975,000.00. Following the completion of the sale, the vice president now directly owns 58,694 shares of the company's stock, valued at $3,521,640. Learn More on Ashley Dreier's trading history.
Who are HealthEquity's active insiders?: HealthEquity's insider roster includes Edward Bloomberg (COO), Frank Corvino (Director), Adrian Dillon (Director), Evelyn Dilsaver (Director), Ashley Dreier (VP), Angelique Hill (VP), Jon Kessler (President, CEO & Director), Delano Ladd (EVP), Debra McCowan (Director), Darcy Mott (Insider), Tyson Murdock (Chief Financial Officer), Stephen Neeleman (Founder, Vice Chairman), William Otten (VP), Stuart Parker (Director), Ian Sacks (Director), Robert Selander (Director), Larry Trittschuh (EVP), and Gayle Wellborn (Director). Learn More on HealthEquity's active insiders.
Are insiders buying or selling shares of HealthEquity?: In the last twelve months, insiders at the sold shares 15 times. They sold a total of 195,205 shares worth more than $16,318,747.82. The most recent insider tranaction occured on December, 12th when Director Stuart B Parker sold 25,000 shares worth more than $2,418,000.00. Insiders at HealthEquity own 2.2% of the company. Learn More about insider trades at HealthEquity.
Information on this page was last updated on 12/12/2024.

Ashley Dreier Insider Trading History at HealthEquity

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/2/2020	Sell	16,250	$60.00	$975,000.00	58,694
1/24/2020	Sell	26,993	$71.02	$1,917,042.86	53,737
5/14/2018	Sell	36,000	$70.94	$2,553,840.00	49,939
5/2/2018	Sell	3,000	$67.00	$201,000.00	36,189
4/30/2018	Sell	16,250	$67.00	$1,088,750.00	49,439
3/22/2018	Sell	71,157	$65.48	$4,659,360.36	21,059
1/29/2018	Sell	12,000	$52.00	$624,000.00	17,652
12/4/2017	Sell	10,000	$50.97	$509,700.00	15,652
9/6/2017	Sell	10,000	$45.50	$455,000.00	15,652
6/5/2017	Sell	10,000	$47.81	$478,100.00	15,652
3/20/2017	Sell	5,000	$45.80	$229,000.00	5,000
11/28/2016	Sell	5,000	$43.38	$216,900.00	5,000
9/1/2016	Sell	10,000	$32.28	$322,800.00	10,000
12/1/2015	Sell	3,125	$32.32	$101,000.00
9/3/2015	Sell	3,125	$30.00	$93,750.00
6/15/2015	Sell	3,125	$28.50	$89,062.50
4/28/2015	Sell	3,125	$27.00	$84,375.00

Ashley Dreier Buying and Selling Activity at HealthEquity

HealthEquity Company Overview

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Today's Range

Now: $94.95

$92.02

$95.58

50 Day Range

MA: $94.99

$83.83

$104.83

2 Week Range

Now: $94.95

$63.87

$105.82

Volume

2,096,834 shs

Average Volume

647,912 shs

Market Capitalization

$8.23 billion

P/E Ratio

87.11

Dividend Yield

N/A

Beta

0.55

Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis

From Weiss Ratings | Ad

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.